DexCom earnings beat by $0.03, revenue topped estimates
Cinemark Holdings, Inc. (NYSE:CNK), the $3.59 billion market cap theater chain operator whose stock has surged nearly 80% over the past year, reported on Tuesday the outcomes of its Annual Meeting of Stockholders held on May 15, 2025. According to InvestingPro analysis, the company is currently trading near its Fair Value. The stockholders voted on several key matters, including the election of board members and approval of executive compensation.
The nominees listed in the company’s proxy statement from April 2, 2025, were elected to the Board of Directors to serve until the 2028 annual meeting. Votes cast for the election of the four nominees were as follows: Benjamin Chereskin received 90,459,674 for and 2,746,112 withheld, Kevin Mitchell received 87,856,990 for and 5,348,796 withheld, Raymond (NSE:RYMD) Syufy received 85,319,228 for and 7,886,558 withheld, and Sean Gamble received 91,269,356 for and 1,936,430 withheld. There were 4,666,919 broker non-votes for each nominee.
The proposal to approve, on an advisory basis, the 2024 compensation of the company’s Named Executive Officers was approved with 92,120,507 votes for, 933,110 against, and 152,169 abstentions, along with 4,666,919 broker non-votes.
Additionally, the selection of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified with 95,347,135 votes for, 2,404,581 against, and 120,989 abstentions.
The results affirm stockholder support for the board’s direction and executive compensation strategy. This confidence is further reflected in management’s aggressive share buyback program and the company’s high shareholder yield, as noted by InvestingPro. The company maintains a "GOOD" financial health score, with particularly strong momentum metrics. The information is based on a press release statement from Cinemark Holdings, Inc. For deeper insights into Cinemark’s financial health and detailed analysis, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, Cinemark Holdings reported its first-quarter 2025 financial results, revealing a mixed performance. The company exceeded revenue expectations, posting $540.7 million against a forecast of $524.2 million, but missed earnings per share estimates with a reported loss of $0.32 per share. Goldman Sachs maintained a Sell rating on Cinemark, setting a price target of $22, while B.Riley initiated coverage with a Neutral rating and a $35 price target. Goldman Sachs highlighted that Cinemark’s revenue exceeded expectations, but its Adjusted EBITDA fell short, marking challenges for the company. The firm also noted potential margin pressures due to rising costs in concessions, wages, and utilities. Cinemark has announced a $200 million stock buyback program to counter potential dilution from an upcoming convertible security. Analysts from B.Riley have adjusted their forecasts for Cinemark, slightly lowering estimates for 2025 and 2026 but maintaining a positive long-term outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.